Golden logo
    Create a WorkspaceQuery ToolSaved QueriesData RequestsListsPipelinesExploreFollowed Topics
    Invite MembersWorkspace SettingsUpgrade to ProPricingAPI AccessHelp & Support
Log in
Sign up
NEW: You can now make knowledge queries using our new natural language prompt. Try it out now!
⟶
Encellin

Encellin

Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.

OverviewStructured DataIssuesContributorsActivity
Contents

Encellin is a biotechnology company based in San Francisco. Encellin is developing diabetes therapeutics using insulin responsive cells. Encellin aims to safely replace missing, damaged, or diseased cells in the body with next generation cell transplants.

In type 1 diabetes (T1D), if the cells that measure sugar and secrete insulin are missing, Encelling performs transplants. However, they are done in only the most severe cases.

Encellin is developing a novel thin-film cell encapsulation device for cell-based therapeutics. With an initial focus on diabetes Encellin plans to encapsulate and replace the cells responsible for making insulin, enabling patients to manage their disease, and have better control over their blood glucose levels.

Timeline

August 9, 2021
Encellin raises $5.9M in Seed financing.
August 9, 2021
Encellin raises a $5,900,000 seed round.

Funding Rounds

Open in Query Tool

Products

Open in Query Tool

Acquisitions

Open in Query Tool

SBIR/STTR Awards

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

Biotech Startups vs Diabetes: Will Encellin Break the Mould?

Darren Wall

https://www.fundz.net/blog/startups-vs-diabetes-will-encellin-break-the-mould

Web

Cell Replacement and Type 1 Diabetes: Encellin's Solution

https://beyondtype1.org/cell-replacement-and-type-1-diabetes-encellins-solution/

Web

January 2, 2018

Encellin - The Stem Cellar

https://blog.cirm.ca.gov/tag/encellin/

Web

September 5, 2019

Encellin is Developing a Cell Therapy Technology to Address Type I Diabetes | Medgadget

https://www.medgadget.com/2017/11/encellin-developing-cell-therapy-technology-address-type-diabetes.html

Web

Grace Wei's Journey from Academia to Encellin Co-Founder and Entrepreneur

Gail Dutton

https://www.biospace.com/article/grace-wei-s-personal-journey-from-academia-to-encellin-co-founder-and-entrepreneur-/

Web

October 5, 2020

References

encellin.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Diabetes mellitus
Diabetes mellitus
Medical device
Medical device
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
...
Location
San Francisco
San Francisco
Mountain View, California
Mountain View, California
B2X
B2B
B2B
CEO
Crystal Nyitray
Crystal Nyitray
Founder
‌
Grace Wei
Crystal Nyitray
Crystal Nyitray
Pitchbook URL
pitchbook.com/profiles...184631-23
Accelerator
Y Combinator
Y Combinator
Accelerator Batch
‌
Y Combinator S19 Batch
Number of Employees (Ranges)
5 – 9
Full Address
Mountain View, US
Investors
Y Combinator
Y Combinator
Khosla Ventures
Khosla Ventures
Sand Hill Angels
Sand Hill Angels
SV Latam Capital
SV Latam Capital
Medtech Innovator
Medtech Innovator
Formic Ventures
Formic Ventures
Founded Date
2016
Email Address
info@encellin.com
Total Funding Amount (USD)
5,900,000
Latest Funding Round Date
August 9, 2021
Glassdoor ID
5302952
Latest Funding Type
Seed round
Seed round
COO
‌
Grace Wei
Wellfound ID
encellin

Other attributes

Company Operating Status
Active
Country
United States
United States
Public/Private
Private
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
OverviewKnowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseProtocolChatGPT Plugin
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.